Yesterday Peter Navarro declared that the US-China trade deal was dead in the water, which his boss quickly walked back on Twitter. In a world of global threats, should bilateral disputes remain our focus, or are we wasting precious time? As I wrote for the G7 Research Group:
Moral Mentors: Sustainability and Corporate Responsibility in Era of Covid-19 and Black Lives Matter
Well before Nike or Starbucks was even a glimmer in the eye of their founders, a little-known economist sat down at his desk in the 1950s in America to write why he believed companies are obliged to be responsible citizens.
I had planned to be in Washington last week at the IMF/World Bank meetings, a chance to hear the latest policy debates and catch up with old friends. Not this spring; the meetings were entirely virtual and didn't offer much clarity beyond a dismal forecast for 2020. I have however indulged in a cornucopia of online offerings, some of which I have included below.
We have another week of data on the US commercial banks’ assets and liabilities. Deposits rose by 2.6% in the week to 25th March, after a (revised) increase of 2.2% in the previous week. The increase in the fortnight to 25th March may have been the highest ever in such a short period of time. The implied annualised rate of increase was not much less than 250%.
The microscopic pathogen that is threatening global health and wreaking havoc from Singapore to Seoul, Tokyo to New York and Berlin to Milan is clearly reshaping the 2020 global outlook. But it should not derail the current momentum driving sustainability investing and corporate governance.
Medicine in the Age of Pandemics: why our innovation system for new drug discovery is failing and how to fix it
Covid-19 is our wake-up call. Deadly pandemics are expected to keep growing in the future and our innovation system for life-saving drug development is ill equipped to deal with it. Here is why and how to fix it.
The ongoing Covid-19 crisis can probably be seen as a “black swan” not only for China but also the whole world. It is largely unpredictable but with severe consequences.
There is no doubt that China has suffered the most from this crisis economically, socially and politically. However, it is highly debatable whether China or the Communist Party is approaching an inflection point of possible breakup or imminent revolution.
The outbreak of the 2019 novel coronavirus is so potentially impactful that we are devoting this entire edition to the epidemic, to an attempt to gauge its seriousness. Some stories are so big that it is hard to get your arms around them and this one definitely fits that category. Social media wasn't a factor during the 2003 SARS epidemic. The Chinese economy was a much smaller percentage of global GDP, and travel to and from China was far less common. So a simple comparison to SARS is not enough.